We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$848M
AUM Growth
+$61.7M
Cap. Flow
+$46.7M
Cap. Flow %
5.51%
Top 10 Hldgs %
57.15%
Holding
999
New
86
Increased
189
Reduced
130
Closed
344

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$10.4M
2
TJX icon
TJX Companies
TJX
+$8.24M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.03M
4
AAPL icon
Apple
AAPL
+$3.4M
5
CARG icon
CarGurus
CARG
+$2.58M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.89M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.15M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.05M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$1.58M
5
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.53M

Sector Composition

Rank Sector Weight
1 Financials 24.85%
2 Technology 11.23%
3 Consumer Discretionary 9.7%
4 Communication Services 3.67%
5 Industrials 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIVO
976
DELISTED
Tivo Inc
TIVO
$0 ﹤0.01%
49
– –
QHC
977
DELISTED
Quorum Health Corporation
QHC
$0 ﹤0.01%
2
– –
CSS
978
DELISTED
CSS Industries, Inc.
CSS
$0 ﹤0.01%
47
– –
WCG
979
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-4
Closed -$1K
SRCI
980
DELISTED
SRC Energy Inc
SRCI
– –
-101
Closed -$1K
MDCO
981
DELISTED
Medicines Co
MDCO
– –
-85
Closed -$2K
ONCE
982
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-59
Closed -$7K
MDSO
983
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-27
Closed -$2K
ALDR
984
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-42
Closed -$1K
BID
985
DELISTED
Sotheby's
BID
– –
-218
Closed -$8K
ARRY
986
DELISTED
Array Biopharma Inc
ARRY
– –
-315
Closed -$8K
ARRS
987
DELISTED
ARRIS International plc Ordinary Shares
ARRS
– –
-160
Closed -$5K
IDTI
988
DELISTED
Integrated Device Technology I
IDTI
– –
-114
Closed -$6K
EMMS
989
DELISTED
Emmis Communications Corp
EMMS
$0 ﹤0.01%
1
– –
BEAT
990
DELISTED
BioTelemetry, Inc.
BEAT
– –
-279
Closed -$18K
ASCMA
991
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$0 ﹤0.01%
64
– –
SIVB
992
DELISTED
SVB Financial Group
SIVB
– –
-15
Closed -$3K
AAWW
993
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
– –
-47
Closed -$2K
FTR
994
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
80
+75
+1,500% +$153
CY
995
DELISTED
Cypress Semiconductor
CY
– –
-187
Closed -$3K
TSS
996
DELISTED
Total System Services, Inc.
TSS
– –
-42
Closed -$4K
FNSR
997
DELISTED
Finisar Corp
FNSR
– –
-487
Closed -$11K
STL
998
DELISTED
Sterling Bancorp
STL
– –
-136
Closed -$3K
CADE
999
DELISTED
Cadence Bancorporation
CADE
– –
-97
Closed -$2K
36 37 38 39
40

Similar funds

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
API
Advisor Partners II Walnut Creek, California $2.49B AUM 30.88% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
SCH
Sylebra Capital (HK) Hong Kong $1.88B AUM 19.75% 1-Year Est. Return
PWAG
Polaris Wealth Advisory Group San Rafael, California $1.31B AUM 17.95% 1-Year Est. Return
CS
Comerica Securities Detroit, Michigan $1.2B AUM 16.58% 1-Year Est. Return
IWP
Icon Wealth Partners Houston, Texas $880M AUM
MAM
Mastrapasqua Asset Management Nashville, Tennessee $853M AUM 37.36% 1-Year Est. Return

Pathstone Family Office's Q2 2019 Portfolio in Review

As of Q2 2019, Pathstone Family Office held 999 positions worth $848M, up 7.8% from $786M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Pathstone Family Office deployed $46.7M of net new capital in Q2 2019, opening 86 new positions and adding to 189 existing holdings. Its largest new stake was Primerica: 18,415 shares worth $2.21M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Merck, an estimated $3.89M trimmed.

  • Pathstone Family Office's largest Q2 2019 buy was Primerica: 18,415 shares worth $2.21M.
  • Pathstone Family Office added most to iShares Russell 1000 ETF in Q2 2019, an estimated $10.4M increase.
  • Pathstone Family Office's biggest Q2 2019 reduction was Merck, cutting an estimated $3.89M.
  • Pathstone Family Office fully exited Xylem in Q2 2019, selling an estimated $983K.
  • Pathstone Family Office's ten largest holdings make up 57% of its $848M portfolio in Q2 2019.
  • Pathstone Family Office opened 86 new positions and closed 344 in Q2 2019.
  • Pathstone Family Office's portfolio value rose 7.8% quarter-over-quarter to $848M.

Based on Pathstone Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.